Speaker
yearbook Logo
Home > NewsRelease > Results of AZALEA and ARTESiA Trials of Afib Stroke Prevention Presented at AHA
Text
Results of AZALEA and ARTESiA Trials of Afib Stroke Prevention Presented at AHA
From:
Mellanie True Hills -- Health and Productivity Expert -- StopAfib Mellanie True Hills -- Health and Productivity Expert -- StopAfib
For Immediate Release:
Dateline: Dallas, TX
Monday, November 27, 2023

 
This month, at the American Heart Association Scientific Sessions held in Philadelphia, several important Afib Late-Breaking Clinical Trials were presented that I want to share with you. These include AZALEA, ARTESiA, and NOAH-AFNET 6. We have posted news stories about them, which you can access here:
Afib News from the American Heart Association Scientific Sessions 2023
P.S. With Giving Tuesday coming up tomorrow, we welcome your support if you’re so inclined. You can donate using the red Donate button at the top of the page at StopAfib.org (or go directly to our donate page at https://fundraise.givesmart.com/form/Z74aUQ).
The post Results of AZALEA and ARTESiA Trials of Afib Stroke Prevention Presented at AHA first appeared on stopafib.
Pickup Short URL to Share
News Media Interview Contact
Name: Mellanie True Hills
Title: CEO
Group: StopAfib.org, American Foundation for Women's Health
Dateline: Greenwood, TX United States
Direct Phone: 940-466-9898
Main Phone: 9404669898
Cell Phone: 940-399-3010
Jump To Mellanie True Hills -- Health and Productivity Expert -- StopAfib Jump To Mellanie True Hills -- Health and Productivity Expert -- StopAfib
Contact Click to Contact